Holen Sie sich die Stockscreener-App
37.86
4.10%
1.49
Schlusskurs vom Vortag:
$36.37
Offen:
$36.34
24-Stunden-Volumen:
366.95K
Relative Volume:
0.44
Marktkapitalisierung:
$1.75B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-146.66M
KGV:
-13.75
EPS:
-2.7541
Netto-Cashflow:
$-133.21M
1W Leistung:
-0.03%
1M Leistung:
+0.29%
6M Leistung:
+20.42%
1J Leistung:
-26.01%
1-Tages-Spanne:
$36.00
$38.00
1-Wochen-Bereich:
$35.68
$38.46
52-Wochen-Spanne:
$26.20
$63.50
Apogee Therapeutics Inc Stock (APGE) Company Profile
Firmenname
Apogee Therapeutics Inc
Sektor
Branche
Telefon
650-394-5230
Adresse
221 CRESCENT ST., WALTHAM
Vergleichen Sie APGE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
APGE
Apogee Therapeutics Inc
|
37.86 | 2.17B | 0 | -146.66M | -133.21M | -2.7541 |
|
VRTX
Vertex Pharmaceuticals Inc
|
401.00 | 100.25B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
577.90 | 61.55B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
447.00 | 58.53B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
706.41 | 43.59B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
332.04 | 33.67B | 3.81B | -644.79M | -669.77M | -6.24 |
Apogee Therapeutics Inc Stock (APGE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-07 | Bestätigt | BTIG Research | Buy |
| 2025-03-13 | Eingeleitet | Citigroup | Buy |
| 2024-11-25 | Eingeleitet | Canaccord Genuity | Buy |
| 2024-05-10 | Eingeleitet | BofA Securities | Buy |
| 2023-12-20 | Eingeleitet | BTIG Research | Buy |
| 2023-08-08 | Eingeleitet | Guggenheim | Buy |
| 2023-08-08 | Eingeleitet | Jefferies | Buy |
| 2023-08-08 | Eingeleitet | Stifel | Buy |
| 2023-08-08 | Eingeleitet | TD Cowen | Outperform |
| 2023-08-08 | Eingeleitet | Wedbush | Outperform |
Alle ansehen
Apogee Therapeutics Inc Aktie (APGE) Neueste Nachrichten
Using data models to predict Apogee Therapeutics Inc. stock movementWeekly Market Summary & Fast Momentum Stock Entry Tips - Newser
Technical analysis overview for Apogee Therapeutics Inc. stockJuly 2025 Update & Low Drawdown Trading Techniques - Newser
Real time pattern detection on Apogee Therapeutics Inc. stock2025 Trading Recap & Technical Entry and Exit Alerts - Newser
Risk adjusted return profile for Apogee Therapeutics Inc. analyzedTrade Signal Summary & Risk Managed Investment Strategies - Newser
What technical models suggest about Apogee Therapeutics Inc.’s comeback - Newser
Can technical indicators confirm Apogee Therapeutics Inc.’s reversalWeekly Investment Report & Free Risk Controlled Daily Trade Plans - Newser
Advanced analytics toolkit walkthrough for Apogee Therapeutics Inc.Quarterly Portfolio Report & Advanced Swing Trade Entry Plans - Newser
Visual analytics tools that track Apogee Therapeutics Inc. performanceJuly 2025 Breakouts & Weekly High Potential Stock Alerts - Newser
Does Apogee Therapeutics Inc. have a sustainable dividendTrend Reversal & Smart Allocation Stock Reports - خودرو بانک
Volume spikes in Apogee Therapeutics Inc. stock – what they meanMarket Risk Report & AI Powered Market Trend Analysis - Newser
Is Apogee Therapeutics Inc. Forming a Bottom Pattern getLinesFromResByArray error: size == 0 - kangso.co.kr
When is the best time to exit Apogee Therapeutics Inc.July 2025 Update & Short-Term Trading Opportunity Alerts - Newser
Will Apogee Therapeutics Inc. bounce back from current supportWeekly Market Report & AI Powered Buy and Sell Recommendations - Newser
Why Apogee Therapeutics Inc. is moving today2025 Growth vs Value & Low Risk Profit Maximizing Plans - Newser
Long term hold vs stop loss in Apogee Therapeutics Inc.2025 Historical Comparison & AI Powered Buy and Sell Recommendations - Newser
Will Apogee Therapeutics Inc. benefit from geopolitical trends2025 Year in Review & Real-Time Buy Signal Alerts - خودرو بانک
Exit strategy if you’re trapped in Apogee Therapeutics Inc.Portfolio Update Summary & Reliable Intraday Trade Plans - Newser
Can Apogee Therapeutics Inc. hit a new high this monthWeekly Gains Report & Expert Approved Trade Ideas - Newser
Apogee Therapeutics Inc. stock momentum explainedGap Down & High Yield Equity Trading Tips - Newser
Analyzing recovery setups for Apogee Therapeutics Inc. investorsJuly 2025 Highlights & Real-Time Buy Signal Notifications - Newser
Comparing Apogee Therapeutics Inc. in custom built stock radarsQuarterly Portfolio Report & Expert Curated Trade Setups - Newser
Smart tools for monitoring Apogee Therapeutics Inc.’s price actionJuly 2025 Trends & Free Low Drawdown Momentum Trade Ideas - Newser
Is Apogee Therapeutics Inc. meeting your algorithmic filter criteriaWeekly Risk Summary & Reliable Volume Spike Trade Alerts - Newser
Understanding Apogee Therapeutics Inc.’s price movement2025 Top Decliners & Technical Pattern Recognition Alerts - Newser
Relative strength of Apogee Therapeutics Inc. in sector analysisJuly 2025 Review & Real-Time Chart Breakout Alerts - Newser
Apogee Therapeutics Inc. Builds Base for Possible Rebound getLinesFromResByArray error: size == 0 - 클래시안
Apogee Therapeutics Inc. stock trend forecastJuly 2025 Fed Impact & AI Based Buy and Sell Signals - Newser
Apogee Therapeutics Inc. stock daily chart insightsWeekly Trade Review & Reliable Trade Execution Plans - Newser
Will Apogee Therapeutics Inc. rebound enough to break evenSell Signal & Capital Efficiency Focused Ideas - Newser
Will a bounce in Apogee Therapeutics Inc. offer an exit2025 Top Gainers & High Conviction Buy Zone Alerts - Newser
Institutional scanner results for Apogee Therapeutics Inc.July 2025 PostEarnings & Verified Trade Idea Suggestions - Newser
Custom watchlist performance reports with Apogee Therapeutics Inc.Market Growth Summary & Long-Term Safe Investment Ideas - Newser
Key resistance and support levels for Apogee Therapeutics Inc.July 2025 Decliners & Fast Entry Momentum Alerts - Newser
Finanzdaten der Apogee Therapeutics Inc-Aktie (APGE)
Umsatz
Nettogewinn
Free Cashflow
ENV
4.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):